Skip to main content
letter
. 2025 Aug 20;11(3):e223. doi: 10.1097/JW9.0000000000000223

Table 1.

Demographics, disease characteristics, and outcome measures

Demographics (N = 156a) No. (%)
Age at time of collection (mean ± SD, range) 37.5 ± 14.6, 14–77
Age at symptom onset (mean ± SD, range) 22.4 ± 12.4, 1–74
Age at HS diagnosis (mean ± SD, range) 30.8 ± 14.6, 10–74
Sex
 Female male 123 (78.8) 33 (21.2)
Race (n = 152)
 White 57 (37.5)
 Black 32 (21.1)
 Asian 10 (6.6)
 Multiracial 3 (2.0)
 Other 50 (32.9)
Ethnicity (n = 144)
 Non-Hispanic Hispanic 100 (69.4) 44 (30.6)
Smoking status (n = 155)
 Never Former Current 117 (75.5) 30 (19.4) 8 (5.2)
Family history of HS (n = 131) 33 (25.2)
BMI classification (n = 152)
 Obese (30+) 84 (55.3)
 Overweight (25 – <30) 37 (24.3)
 Normal weight (18.5 – <25) 29 (19.1)
 Underweight (<18.5) 2 (1.3)
Hurley stage (n = 155)
 I / II / III 20 (12.9) 84 (54.2) 51 (32.9)
Pain score (mean ± SD, range) 3.3 ± 3.1, 0–10
Itch score (mean ± SD, range) 2.9 ± 3.1, 0–10
Drainage (n = 155)
 None Mild Moderate Severe 69 (44.5) 52 (33.5) 26 (16.8) 8 (5.2)
DLQI (mean ± SD, range) (n=152) 10.8 ± 7.8, 0–30

BMI, body mass index; DLQI, Dermatology Life Quality Index; HS, hidradenitis suppurativa; SD, standard deviation.

a

Unless otherwise specified.